All-in-One Report for National Stock Number: 6505013366182, Part Number: 2602837

All-in-One Report Demo (NSN: 6505013366182, Part Number: 2602837)

Master Cross Reference Data (MCRD) - alternate part numbers for national stock numbers
NSN
Description
MCRL Information

6505013366182

CEFTAZIDIME FOR INJECTION

INC: 42844
HMIC:
ESDC: P
ENAC:
Cancelled By:


Part #	MCRL Information	CAGE Code Phone Fax	Company Name Address

2602837	ISC: 5 RNVC: 9 RNCC: 6 DAC: 9	Details Available Details Available Details Available	Details Available Details Available
5425025651269	ISC: 5 RNVC: 2 RNCC: 5 DAC: U	Details Available Details Available Details Available	Details Available Details Available
CEFTAZIDIM 1000MG 10ML 10FLACONS	ISC: 5 RNVC: 2 RNCC: 5 DAC: 4	Details Available Details Available Details Available	Details Available Details Available
CEPTAZ	ISC: 5 RNVC: 1 RNCC: 5 DAC: 4	Details Available Details Available Details Available	Details Available Details Available
NDC00173-0416-00	ISC: 5 RNVC: 2 RNCC: 3 DAC: 4	Details Available Details Available Details Available	Details Available Details Available

Procurement History - US Gov't Purchase History

NSN
Contract #
Delivery Order #
SOS

Date
Line Item #

Price

QTY (U / M)

CAGE Code
Phone
Fax

Company Name
Address

6505013366182

DLA12093A1025

E847

DSCP

1993-04-17
0001

3 (PG)

Details Available
Details Available

6505013366182

DLA12093A1025

1993-04-17

3 (PG)

Details Available
Details Available

6505013366182

DLA12093A1025

1993-04-17

3 (PG)

Details Available
Details Available

Technical Characteristics - detailed information such as measurements and material type for national stock numbers

NSN
Item Name

Technical Characteristics

6505-013366182

CEFTAZIDIME FOR INJECTION

MRC	Requirements	Characteristics
MDES	MEDICAL DESIGNATION AND GRADE	Details Available
CRLK	PRIMARY CONTAINER CONTENT QUANTITY	Details Available
FEAT	SPECIAL FEATURES	Details Available
CSCW	TOTAL PRIMARY CONTAINER QUANTITY	Details Available
AKJA	ACTIVE MEDICAMENT MEDICINAL STRENGTH	Details Available